Bipartisan support for New Zealand's Medicinal Cannabis Scheme amendments, streamlining licensing and exporting.
Long-awaited amendments to New Zealand's Medicinal Cannabis Scheme receive bipartisan support, allowing companies to immediately export. The changes streamline licensing, update testing and lab requirements, and lower export ingredient testing costs without affecting quality. The amendments enable cultivators and manufacturers to access the growing global demand for medicinal cannabis.
July 08, 2024
3 Articles